79.00
-2.65(-3.25%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1556
First IPO Date
June 21, 2021
| Name | Title | Pay | Year Born |
| Mr. Huan Luo | Deputy GM & Director | 0 | 1984 |
| Mr. Xie Daosheng | Core Technical Staff | 0 | 1985 |
| Mr. Yujing Liu | GM & Director | 0 | 1982 |
| Mr. Yuanbo Li | Deputy General Manager | 0 | 1979 |
| Mr. Guangtao Hao | Deputy GM & Core Technician | 0 | 1980 |
| Ms. Yan Shao | Deputy General Manager | 0 | 1978 |
| Mr. Gao Jian | Core Technical Staff | 0 | 1981 |
| Ms. Wang Mingjuan | Core Technical Staff | 0 | 1976 |
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokinetics-pharmacodynamics and GLP bioanalysis services, including pharmacokinetic bioanalysis, immunogenic biology analysis, pharmacodynamics, and biomarker bioanalysis services. The company was founded in 2009 and is based in Beijing, China.
